Nie masz uprawnień do wyświetlenia tego obiektu. Aby poprosić o dostęp do niego, wypełnij poniższe pola.
Trąbka-Zawicki, Aleksander
2019
Praca doktorska
In the group of patients admitted for interventional management of acute coronary syndrome complicated with cardiac arrest, significant inhibition of platelet activity in response to ticagrelor - a novel P2Y12 receptor inhibitor - has been documented in mild therapeutic hypothermia (MTH) conditions (32-34 degrees Celsius). The degree of platelet activity inhibition in this group was similar to the control group - conscious acute coronary syndrome patients treated interventionally in normothermic condition.Clinical efficiency of dual antiplatelet therapy (DAPT), consisting of ticagrelor, a novel oral P2Y12 receptor inhibitor, in combination with acetylsalicylic acid, as a therapy supportive to PCI in MTH conditions in out-of-hospital cardiac arrest (OHCA) patients, defined as freedom from thromboembolic events, has been confirmed. However, increased numbers of severe bleeding complications was observed in this group, what required intensive care unit (ICU) monitoring and blood transfusion therapy.Further clinical course and neurological condition in this group was favourable and dependent on cardiac arrest mechanism, occurrence and timing of early cardiopulmonary resuscitation, time to return of spontaneous circulation, lack of shock and renal failure, and, independently, on e
Kraków
2 - studia doktoranckie
choroby układu krążenia
Wydział Lekarski
Żmudka, Krzysztof
2017
oai:dl.cm-uj.krakow.pl:4387
ZB-130895
pol
nieograniczony
26 cze 2023
13 paź 2020
149
214
http://dl.cm-uj.krakow.pl:8080/publication/4388
RDF
OAI-PMH
Cebula, Grzegorz
Gorzkowska, Maria
Jarosz, Anna
Plicner, Dariusz
Zeliaś, Aleksander
Rebes, Katarzyna
Marcinkowski, Marcin
Styl cytowania: chicago-author-date iso690-author-date
Ta strona wykorzystuje pliki 'cookies'. Więcej informacji Rozumiem